BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Shanghai ArkBio Completes Phase III Trial of AK0901 for Pediatric ADHD in China

Shanghai Ark Biopharmaceutical Co., Ltd. announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of a...

March 25, 2025 | News

GSK’s Omjjara Receives Local Approval in Singapore for Myelofibrosis Patients with Moderate to Severe Anaemia

Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib Nearly all myelof...

March 25, 2025 | News

LISCure Biosciences Secures World’s First Regulatory Approval for Hair Health Probiotic, Mobiome®, in South Korea

LISCure Biosciences Inc. ("LISCure") announced on the 2025 Feb that it has received approval from the Korean Ministry of Food and Drug Safety (KM...

March 21, 2025 | News

TPIsoftware & Yuan's General Hospital Transform Healthcare with GenAI Platform

TPIsoftware (TWSE: 7781) and Yuan's General Hospital, a leading medical institution in Southern Taiwan, have collaborated to launch a digit...

March 20, 2025 | News

Formosa Pharmaceuticals and Cipla Sign Multi-Regional Licensing Deal for Ophthalmic Suspension APP13007

Taiwan-based Formosa Pharmaceuticals announced an exclusive licensing agreement with Cipla Limited referred to as "Cipla" for the commercialization of clob...

March 19, 2025 | News

Vatech and Pearl Partner to Elevate Dental AI Diagnostics with Seamless Integration

Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at tra...

March 19, 2025 | News

VISTA Eye Specialist Advances Cataract Surgery in Malaysia with AI and Leading Ophthalmic Technologies

Klinik Pakar Mata VISTA Eye Specialist (VISTA), a well-established name in eye care in Malaysia, continues to improve its cataract surg...

March 17, 2025 | News

Teva Hong Kong Partners with Kerry Pharma to Enhance Medicine Distribution Across Hong Kong, Macau, and the Greater Bay Area

Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Ke...

March 17, 2025 | News

Ascletis’ ASC47 Shows Promise as a Long-Acting, Muscle-Preserving Obesity Treatment in Phase Ib Study

ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and ...

March 12, 2025 | News

AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia

Chronic kidney disease (CKD) is a growing public health challenge in Asia, affecting over 400 million people. In an insightful discussion with BioPharma AP...

March 12, 2025 | News

Gleneagles Hospital Hong Kong Becomes Asia’s First Private Hospital to Offer Histotripsy for Liver Cancer Treatment

Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative...

March 11, 2025 | News

South Korea’s Lunit AI Proven to Enhance Breast Cancer Detection in Landmark Multicenter Study

Lunit, a global leader in AI-powered cancer diagnostics, has announced groundbreaking results from the world’s first large-scale, multicenter, prospe...

March 11, 2025 | News

Docquity Partners with RSUD Umar Wirahadikusumah Sumedang to Enhance Healthcare with AI-Powered Medical Resource Platform Dx

Dx, Docquity's AI platform which is in ongoing development, will enable physicians at the Sumedang hospital to securely access the latest medical re...

March 07, 2025 | News

NEXTBIOMEDICAL’s Nexsphere-F™ Secures FDA Breakthrough Device Designation for Osteoarthritis Pain Treatment

NEXTBIOMEDICAL CO., LTD, a leading developer of cutting-edge Devices, announced that its groundbreaking product 'Nexsphere-F™,' a resorbable microsph...

March 07, 2025 | News

Stay Connected